Literature DB >> 9248776

Involvement of the rat gut epithelial and muscular layer, and microflora in chiral inversion and acyl-glucuronidation of R-fenoprofen.

S Sattari1, F Jamali.   

Abstract

In the presence of excised human and rat gut, the pharmacologically inactive R enantiomers of both ibuprofen and fenoprofen (FN) are bioinverted to their anti-inflammatory antipodes. In an attempt to further localize the site of inversion, we incubated R-FN, in oxygenated (O2:CO2, 95:5, v/v) Krebs-Henseleit solution (37 degrees C, pH 7.4) for 3 h in the presence of the intestinal contents, epithelium and muscular layer of upper jejunum and everted jejunum sack of antibiotic treated (500 mg/kg neomycin and erythromycin b.i.d. for 3 days) and control adult female Sprague-Dawley rats. The formation of S-FN and acylglucuronidated FN was examined in the incubation medium using a stereospecific HPLC assay. The metabolic activities are reported per g of wet tissue. The extent of inversion by the everted rat gut was substantial (30.7 +/- 5.1%) but no significant differences between the control and germ-eradicated rats was observed. The epithelial cells were found to be the major site of inversion in the intestinal wall (37.5 +/- 4.7%) with the muscular layer (7.8 +/- 2.1%) and intestinal contents (5.7 +/- 2.2%) contributing only to a small extent to the process. Both enantiomers were substantially acyl-glucuconjugated in the epithelial and muscular layers, and the intestinal content.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248776     DOI: 10.1007/BF03189791

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  19 in total

Review 1.  Metabolism of drugs and other xenobiotics in the gut lumen and wall.

Authors:  K F Ilett; L B Tee; P T Reeves; R F Minchin
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 2.  Metabolism of hormones, drugs and other substances by the gut.

Authors:  K Hartiala
Journal:  Physiol Rev       Date:  1973-04       Impact factor: 37.312

3.  Extracellular space in the epithelium of rats' small intestine.

Authors:  G Esposito; T Z Csáky
Journal:  Am J Physiol       Date:  1974-01

4.  Xenobiotic metabolism by isolated intestinal epithelial cells from guinea-pigs.

Authors:  J R Dawson; J W Bridges
Journal:  Biochem Pharmacol       Date:  1979-11-15       Impact factor: 5.858

5.  Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions.

Authors:  P K Konturek; T Brzozowski; S J Konturek; A Dembiński
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

6.  Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--1. In vitro studies of ibuprofen and flurbiprofen.

Authors:  R D Knihinicki; K M Williams; R O Day
Journal:  Biochem Pharmacol       Date:  1989-12-15       Impact factor: 5.858

7.  Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A.

Authors:  T S Tracy; S D Hall
Journal:  Drug Metab Dispos       Date:  1992 Mar-Apr       Impact factor: 3.922

8.  Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates.

Authors:  F Jamali; N N Singh; F M Pasutto; A S Russell; R T Coutts
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

9.  Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans.

Authors:  A Rubin; M P Knadler; P P Ho; L D Bechtol; R L Wolen
Journal:  J Pharm Sci       Date:  1985-01       Impact factor: 3.534

10.  Stereospecific inversion of (R)-(-)-benoxaprofen in rat and man.

Authors:  R G Simmonds; T J Woodage; S M Duff; J N Green
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

View more
  1 in total

1.  A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.

Authors:  Min Ye; Swati Nagar; Ken Korzekwa
Journal:  Biopharm Drug Dispos       Date:  2016-04       Impact factor: 1.627

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.